Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

4.415 -0.075 (-1.67%)
Streaming Delayed Price Updated: 11:43 AM EDT, Apr 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Taysha Gene Therapies, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million. 
Via Benzinga
News headline image
Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
S&P 500 Rises Over 1%; General Motors Earnings Top Views ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 200 companies hit new 52-week lows. 
Via Benzinga
News headline image
Expert Ratings for Taysha Gene Therapies ↗
Within the last quarter, Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings: 
Via Benzinga
News headline image
Taysha Gene Therapies: Q1 Earnings Insights ↗
Taysha Gene Therapies (NASDAQ:TSHA) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Earnings Scheduled For May 16, 2022 ↗
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
News headline image
Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Analyzing Taysha Gene Therapies's Short Interest ↗
Taysha Gene Therapies's (NASDAQ:TSHA) short percent of float has fallen 5.27% since its last report. The company recently reported that it has 889 thousand shares sold short, which is 4.31% of all... 
Via Benzinga
News headline image
Why Is Xerox (XRX) Stock Down 20% Today? ↗
Xerox (XRX) stock is heading lower on Tuesday thanks to the release of its earnings report for the third quarter of 2022. 
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. 
Via Benzinga
News headline image
Taysha Gene Therapies Lays Off 35% Of staff, Narrows R&D Focus ↗
Taysha Gene Therapies Inc (NASDAQ: TSHA) is the latest company to slim down by  
Via Benzinga
News headline image
Taysha Gene Therapies (NASDAQ: TSHA) Receives $50 Million Strategic Investment From Astellas Pharma to Develop AAV-Based Gene Therapeutics
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is a biotechnology company that is focused on developing gene therapies to treat monogenic 
Via Spotlight Growth
News headline image
What Is Going on With Taysha Gene (TSHA) Stock Today? ↗
Taysha and its new partner Astellas are both speculating that Adeno Associated Viruses can create treatments for genetic diseases. 
Via InvestorPlace
News headline image
Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Taysha Gene Therapies (NASDAQ:TSHA) stock increased by 36.4% to $2.06 during Tuesday's pre-market session. The market value of their outstanding shares is at $84.6 million. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning! 
Via InvestorPlace
News headline image
Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket ↗
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose 43% to $2.16 in pre-market trading. Astellas Pharma Inc. announced plans to invest a total of $50 million to acquire 15% of Taysha Gene... 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Taysha Gene Therapies ↗
  Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 215 companies set new 52-week lows. 
Via Benzinga
News headline image
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday ↗
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
On Tuesday, 540 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
On Monday, 198 companies reached new 52-week lows. 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Taysha Gene Therapies ↗
Analysts have provided the following ratings for Taysha Gene Therapies (NASDAQ:TSHA) within the last quarter: 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Friday ↗
Wells Fargo lowered the price target on General Motors Company (NYSE: GM) from $83 to $72. GM shares rose 0.8% to $44.10 in pre-market trading. 
Via Benzinga
News headline image
Recap: Taysha Gene Therapies Q4 Earnings ↗
  Taysha Gene Therapies (NASDAQ:TSHA) reported its Q4 earnings results on Thursday, March 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
On Friday, 213 companies hit new 52-week lows. 
Via Benzinga
News headline image
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.